- Main
TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis
- Ganz, Tomas;
- Nemeth, Elizabeta;
- Rivella, Stefano;
- Goldberg, Paul;
- Dibble, Andrew R;
- McCaleb, Michael L;
- Guo, Shuling;
- Monia, Brett P;
- Barrett, Terrance D
Published Web Location
https://doi.org/10.1007/s12325-022-02421-wAbstract
TMPRSS6 is a serine protease highly expressed in the liver. Its role in iron regulation was first reported in 2008 when mutations in TMPRSS6 were shown to be the cause of iron-refractory iron deficiency anemia (IRIDA) in humans and in mouse models. TMPRSS6 functions as a negative regulator of the expression of the systemic iron-regulatory hormone hepcidin. Over the last decade and a half, growing understanding of TMPRSS6 biology and mechanism of action has enabled development of new therapeutic approaches for patients with diseases of erythropoiesis and iron homeostasis.ClinicalTrials.gov identifier NCT03165864.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.